Subscribe

PROMOCODE 
The lives of people with cancer are measured in birthdays, graduations, weddings and anniversaries.

Every day is valuable to patients and to their loved ones.

Life-Years Saved from Cancer Since 1990

Meet Terry Barter

Terry Barter was the first patient to receive a new cancer medication at the Dana Farber Cancer Institute in Boston Read more...

Meet Bob Tufts

Bob Tufts is a former major league baseball player with a degree in Economics from Princeton University Read more...

Meet Lynne Jacoby - In Memorial

In April 2012, Lynne B. Jacoby was diagnosed with metastatic pancreatic cancer, one of the most difficult cancers to treat. Read more...

Meet Don Wright

Marathoner Don Wright is on his way to running 100 marathons, even though he is 73 years old and is undergoing treatment for Read more...

Cancer therapies have made a great deal of progress in recent years, but access to this progress is at risk. Cancer patients are often told that treatments giving them a few more weeks aren’t worth it? But increasingly, living even two weeks longer can mean a fuller and even longer life. New medicines that target specific tumors not only improve well-being, they give people the chance to try a series of new treatments that can allow people to become cancer free.

Reel Innovation Video Series

Latest News

Accelerated Access to New Treatments a “Moral Imperative” Says John Morrissey of the Schulze Family Foundation

In a powerful and thought-provoking editorial recently published on The Hill, John Morrissey – the Chair of the Scientific Advisory Board of the Richard M. Schulze Family Foundation – deemed the accel…

More

New Clinical Trials Demonstrate ABRAXANE®’s Efficacy in High Risk Early Breast Cancer

The German Breast Group (GBG) said ABRAXANE (nab-paclitaxel) demonstrated significant benefit for patients with early high risk breast cancer when compared to conventional chemotherapy (solvent-based …

More

Center for Medicine in the Public Interest & Worldview Honor Top Medical Innovators in Hematology

The Center for Medicine in the Public Interest (CMPI) joined with Scientific American Worldview to recognize Worldview’s Top Medical Innovators, four scientists whose work has transformed the diagnosi…

More